In the same way, it is possible that activation of FPR via the prion peptide fragment PrP106-126, another known FPR agonist [16], may exacerbate the progression of prion disease, in which ROS generation and microglial activation are known to contribute to disease pathogenesis [44]. This evidence concerns the gene FPR1 and prion disease.